Keywords: imclone, 1st-qtr, net, losses, reach, million, systems
ImClone's 1st-qtr net losses reach $30 million
Article | 27 May 2002
ImClone Systems has reported total revenues of $18.6 million forfirst-quarter 2001, down a significant 33.6% on the like, year-earlier period. The firm's net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
